Want to join the conversation?
$LCRX stated that 4Q15 revenue totaled $1.426Bil, a bit above the midpoint of guidance and down 11% vs. the record high level seen in 3Q15. GM for the quarter came in at the midpoint of guidance at 45.5%, and some QtoQ variability is expected to be seen in GM due to product mix, customer concentration and overall business volumes.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)